Hayat Biotech
UAE-based biotechnology company focused on vaccine and biologics R&D, clinical trials, manufacturing and global distribution. Operates large-scale manufacturing and automated warehousing facilities, conducts multi-site clinical trials, and integrates data analytics and AI into clinical and R&D workflows. Emphasises public-private partnerships, One Health principles, and regional/global supply-chain capabilities.
Industries
Nr. of Employees
medium (51-250)
Hayat Biotech
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
Products
Inactivated COVID‑19 vaccine (regional manufacture and distribution)
Production and distribution of an inactivated COVID‑19 vaccine registered in multiple countries, maintained as a strategic stockpile and distributed internationally during the pandemic response.
Hayat-Vax
The first COVID-19 vaccine to be produced in the Arab world, manufactured as a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42.
Contract Manufacturing Organization
Pharmaceutical development and manufacturing solutions providing pharmaceutical manufacturing amenities on a contractual basis.
Inactivated COVID‑19 vaccine (regional manufacture and distribution)
Production and distribution of an inactivated COVID‑19 vaccine registered in multiple countries, maintained as a strategic stockpile and distributed internationally during the pandemic response.
Hayat-Vax
The first COVID-19 vaccine to be produced in the Arab world, manufactured as a joint collaboration between Sinopharm CNBG and Abu Dhabi’s G42.
Contract Manufacturing Organization
Pharmaceutical development and manufacturing solutions providing pharmaceutical manufacturing amenities on a contractual basis.
Services
On-site contract manufacturing and fill–finish for vaccines and biologics, including high-speed automated lines and capacity for large annual output.
Design and delivery of multi-site clinical trials including large Phase III studies, participant recruitment across diverse populations and collaboration with national health authorities.
International distribution networks and regional hubs to support supply, stockpiling and delivery of temperature-sensitive medicines and vaccines.
Collaborative research and development programs with academic and industry partners, plus technology transfer to enable local production and capability building.
On-site contract manufacturing and fill–finish for vaccines and biologics, including high-speed automated lines and capacity for large annual output.
Design and delivery of multi-site clinical trials including large Phase III studies, participant recruitment across diverse populations and collaboration with national health authorities.
International distribution networks and regional hubs to support supply, stockpiling and delivery of temperature-sensitive medicines and vaccines.
Collaborative research and development programs with academic and industry partners, plus technology transfer to enable local production and capability building.
Expertise Areas
- Clinical trial management
- Vaccine and biologics manufacturing
- Contract manufacturing (CMO) services
- Supply chain and cold-chain logistics
Key Technologies
- Automated fill–finish and high-speed packaging
- Cold-chain storage and automated warehousing
- Inactivated vaccine manufacturing
- Pre-filled syringe (PFS) production
News & Updates
Article by the Deputy CEO describing international partnerships, capacity building, production capacity and clinical trial management to improve medicine access.
Profile describing construction and commissioning of a life sciences park, production capacities, automated warehouses and One Health approach to manufacturing and distribution.
Summary of the 4Humanity trial: a large Phase III inactivated vaccine study involving over 44,000 volunteers and coordination with national health authorities.
Reported delivery of millions of vaccine doses internationally during the COVID‑19 pandemic and maintenance of a strategic stockpile.
Senior executive listed among regional healthcare leaders and recipients of industry recognition at healthcare summits.
Article by the Deputy CEO describing international partnerships, capacity building, production capacity and clinical trial management to improve medicine access.
Profile describing construction and commissioning of a life sciences park, production capacities, automated warehouses and One Health approach to manufacturing and distribution.
Summary of the 4Humanity trial: a large Phase III inactivated vaccine study involving over 44,000 volunteers and coordination with national health authorities.
Reported delivery of millions of vaccine doses internationally during the COVID‑19 pandemic and maintenance of a strategic stockpile.
Senior executive listed among regional healthcare leaders and recipients of industry recognition at healthcare summits.